Inactive Instrument

Tibet Pharmaceuticals, Inc. Stock Other OTC

Equities

TBET

VGG886151023

Pharmaceuticals

Sales 2009 23.01M Sales 2010 32.36M Capitalization 14
Net income 2009 9M Net income 2010 13M EV / Sales 2009 * -
Net cash position 2009 * - Net cash position 2010 * - EV / Sales 2010 * -
P/E ratio 2009 *
-
P/E ratio 2010 *
-
Employees -
Yield 2009 *
-
Yield 2010 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Tibet Pharmaceuticals, Inc., formerly Shangri-La Tibetan Pharmaceuticals, Inc., is a specialty pharmaceutical company focusing on the research, development, manufacturing and marketing of Tibetan medicines. The Company sells both prescription and over-the-counter traditional Tibetan medicines. As of December 31, 2009, it had developed five pharmaceutical products. The Company sells its products principally to distributors in People's Republic of China, who in turn sell them to hospitals, hospital pharmacies and retail pharmacies. The Company’s products include 25 Ingredients Mandrake Pill, 28 Ingredients Pinang Pill, 18 Ingredients Chebulic (Myrobalan) Frusemide Pill, 15 Ingredients Gentiana Pill and Pomegranate Nichirin Pill.
More about the company